DUBLIN, May 16, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "The Global Market for Biomarkers (Cancer Markers, Cardiac Markers, Immunological Disease Markers, Infectious Disease Markers, Others)" report to their offering.
Biomarkers can be used for a range of diagnostic applications including predicting disease risk, diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications. Biomarkers also have important roles in drug discovery and development.
The biomarker market is large, reflecting the large market for diagnostic tests based on these biomarkers, and also the ongoing efforts to discovery, validate, and commercialize new biomarkers. Growth in this market is fueled by factors that are fostering the growth of both the research and the diagnostics market. Market drivers and challenges are discussed in the report.
The large and growing biomarker market has attracted a lot of attention, and companies entering the market. Thus this has become a highly competitive market. The report profiles companies involved in the biomarkers market.
The information presented in this report is derived from publicly available information sources such as company reports and announcements, government reports and databases, medical organization reports, medical associations, and other publications. The analysis is based on the author's industry knowledge combined with literature searches and discussions with industry professionals and experts in the areas of point-of-care tests, decentralized healthcare and healthcare economics.
Key Topics Covered:
1 - Executive Summary
2 - Introduction
3 - Selected Technologies Used to identify & analyze Biomarkers
4 - Cancer Biomarkers
5 - Cardiovascular Disease Biomarkers
6 - Immunological Disease Biomarkers
7 - Infectious Disease Biomarkers
8 - Neurological Disease Biomarkers
9 - Novel Biomarkers for other diseases
10 - Deals
11 - Market Drivers and Challenge
12 - Biomarker Market Analysis
13 - Company Profiles: Biomarker Companies
- 14M Genomics Ltd.
- 20/20 GeneSystems, Inc
- 23andMe, Inc.
- A&G Pharmaceutical, Inc.
- ACT Genomics Co., Ltd.
- AESKU.DIAGNOSTICS
- ALPCO
- AXO Science
- Abacus Diagnostica Oy
- Abbott Laboratories
- Abcodia Ltd.
- Accelerate Diagnostics, Inc.
- Acobiom
- Acumen Pharmaceuticals, Inc.
- Adaptive Biotechnologies Corporation
- Adlyfe Inc.
- Admera Health (A GENEWIZ Company)
- Affymetrix, Inc.
- Agena Bioscience Inc.
- Agendia NV
- Agilent Technologies Inc.
- Alere Inc.
- Almac Group Limited
- Amarantus BioScience Holdings, Inc.
- Ambry Genetics Corp.
- Aperiomics, Inc.
- ApoCell, Inc.
- Applied Proteomics, Inc.
- Associates of Cape Cod, Inc. (ACC)
- Asuragen, Inc.
- AsymmetRx Medical, Inc.
- Athena Diagnostics, Inc. (A Quest Diagnostics Business)
- Atlas Genetics Ltd
- Atossa Genetics Inc.
- Augurex Life Sciences Corp.
- Augurix SA/Augurix Diagnostics
- Avant Diagnostics, Inc. (Formerly Arrayit Diagnostics Inc.)
- Axela, Inc
- Axis-Shield Diagnostics, Ltd. (An Alere Company)
- BG Medicine, Inc.
- BIOUNIVERSA s.r.l.
- Banyan Biomarkers, Inc.
- Beckman Coulter, Inc.
- Becton, Dickinson and Company (BD)
- Bio-Rad Laboratories, Inc.
- BioFire Diagnostics, LLC (Acquired by bioMérieux)
- BioMarker Strategies
- BioMedomics, Inc.
- BioMosaics Inc.
- BioPorto Diagnostics A/S
- BioSystems International
- Biocartis SA
- Biocrates Life Sciences AG
- Biodesix, Inc.
- Biohit Oyj
- Bioinnovation Solutions SA
- Biotype Diagnostic GmbH
- CD Diagnostics, Inc.
- Cancer Genetics, Inc.
- Caprion, Inc.
- CardioDx, Inc.
- CardioGenics Holdings Inc.
- CareDx, Inc.
- Caris Life Sciences
- Castle Biosciences, Inc.
- Cellmid Ltd.
- Centogene AG
- Cepheid
- Chronix Biomedical, Inc.
- Clarient Diagnostic Services, Inc. (A GE Healthcare Company; Being Acquired by
- Company Overview
- Courtagen Life Sciences, Inc.
- Crescendo Bioscience (Subsidiary of Myriad Genetics)
- Critical Diagnostics
- Curetis AG
- Cynvenio Biosystems, Inc.
- DNA Electronics Ltd. (DNAe)
- Dako A/S (An Agilent Company)
- Danaher Corporation
- DiaGenic ASA
- Diadexus, Inc
- Diagenics International Corporation
- Diagenics SE
- Diaxonhit
- EntroGen, Inc.
- Epic Sciences, Inc.
- Epigenomics AG
- Epinex Diagnostics, Inc.
- Eutropics Pharmaceuticals
- Exact Sciences Corporation
- Exiqon A/S
- Foundation Medicine, Inc.
- Fujirebio Diagnositics, Inc.
- Fujirebio Inc.
- Gamma Therapeutics, Inc.
- Genalyte, Inc.
- GeneCentric Diagnostics, Inc.
- GeneNews Limited and Innovative Diagnostic Laboratory
- Genection, Inc. (An Invivoscribe Company)
- GenomeDx Biosciences
- Genomeon LLC
- Genomic Health, Inc.
- Genomic Vision
- Genoptix (A Novartis Company)
- Guardant Health, Inc.
- HalioDx
- Helomics Corporation
- Hologic, Inc.
- Illumina, Inc.
- Immunexpress
- Integrated Diagnostics, Inc.
- Intrinsic LifeSciences
- Myriad Genetics, Inc.
- NanoString Technologies, Inc.
- NeoGenomics, Inc.)
- NeoGenomics, Inc./NeoGenomics Laboratories
- OPKO Health, Inc./OPKO Diagnostics
- ORGENTEC Diagnostika GmbH
- Oncolab, Inc.
- Oncospire Genomics
- Orion Genomics
- Ortho-Clinical Diagnostics
- Oxford Gene Technology
- Proteome Sciences plc
- Psynova Neurotech Ltd.
- QIAGEN N.V.
- Quanterix Corporation
- RENESE UG
- Randox Laboratories Ltd
- Rapid Pathogen Screening, Inc.
- ReLIA Diagnostics, Inc.
- Recent Revenue History and Other Financial Information
- Roche
- Siemens Healthcare Diagnostics
- Sysmex Corporation
- The Binding Site Group Ltd.
- Thermo Fisher Scientific, Inc.
- Tosoh Corporation
- Ventana Medical Systems, Inc. (Member of the Roche Group)
- Wako Pure Chemical Industries, Ltd.,
- XRGenomics LTD
- ZEUS Scientific, Inc.
- bioMérieux SA
- bioTheranostics, Inc. (A bioMérieux Company)
- deCODE genetics
For more information visit http://www.researchandmarkets.com/research/dvxsvq/the_global_market
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Media Contact:
